DELALUTIN Side Effects

6434663-6 | Abnormal Behaviour, Chromosomal Deletion, Congenital Anomaly, Congenital Tricuspid Valve Incompetence, Cytogenetic Abnormality, Emotional Disorder, Fine Motor Delay, Foetal Alcohol Syndrome
on Nov 09, 2009 Male patient from UNITED STATES , weighting 6.25 lb, was diagnosed with luteal phase deficiency, prophylaxis and was treated with Delalutin (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, chromosomal deletion, congenital anomaly, congenital tricuspid valve incompetence, cytogenetic abnormality, emotional disorder, fine motor delay, foetal alcohol syndrome. Delalutin dosage: 250mg Once A Week Im; Gestation Wks 5-17. During the same period patient was treated with WINE (View Wine Review and Wine Label ). Patient was hospitalized and became disabled.

6093715-3 | Alcohol Interaction, Chromosomal Deletion, Ebstein's Anomaly, Heart Disease Congenital, Microcephaly
Patient was taking Delalutin (View Usage). Patient had the following side effects: alcohol interaction, chromosomal deletion, ebstein's anomaly, heart disease congenital, microcephaly on Feb 23, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 6.00 lb, was diagnosed with luteal phase deficiency and. Delalutin dosage: 250 Mg Once A Week Im. Patient was hospitalized.

5589219-4 | Alcohol Interaction
Adverse event was reported on Jan 09, 2008 by a Male patient taking Delalutin (View Usage) (Dosage: 250 Mg 1 Injection/week Intramuscular (dates Of Use: Gestation Wk )) was diagnosed with alcohol use and. Location: UNITED STATES , weighting 6.00 lb, After Delalutin was administered, patient had the following side effects: alcohol interaction. Patient was hospitalized and became disabled.

5419046-X | Alcohol Interaction, Atrial Septal Defect, Atrioventricular Septal Defect, Chromosomal Deletion, Ebstein's Anomaly
on Aug 17, 2007 Male patient from UNITED STATES , weighting 6.00 lb, was treated with Delalutin (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol interaction, atrial septal defect, atrioventricular septal defect, chromosomal deletion, ebstein's anomaly. Delalutin dosage: 250 Mg 1 Injection/week Intramuscular. During the same period patient was treated with ALCOHOL/RED WINE 12.2% ABSOLUTE ALCOHOL (0.5 Ounces Wine One Sip Oral) (View Alcohol/red Wine -12.2% Absolute Alcohol Review and Alcohol/red Wine -12.2% Absolute Alcohol Label ). Patient was hospitalized and became disabled.


5368836-0 | Alcohol Interaction, Atrial Septal Defect, Atrioventricular Septal Defect, Chromosomal Deletion, Ebstein's Anomaly
on Jun 21, 2007 Male patient from UNITED STATES , weighting 6.00 lb, was diagnosed with ovarian failure and was treated with Delalutin (View Usage). Patient had the following side effects: alcohol interaction, atrial septal defect, atrioventricular septal defect, chromosomal deletion, ebstein's anomaly. Delalutin dosage: 250 Mg 1 Injection/week Im. Patient was hospitalized.

5142984-2 | Alcohol Interaction
Patient was taking Delalutin (View Usage). After Delalutin was administered, patient had the following side effects: alcohol interaction on Oct 31, 2006 from UNITED STATES Additional patient health information: Female patient , 32 years of age, weighting 150.0 lb, was diagnosed with ovarian disorder and. Delalutin dosage: 250 Mg/week 5-17- Im.